Collecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
Jiang Liu
Advertisement
Articles by Jiang Liu
Advertisement
Latest Updated Articles
PK in Late Phase TrialsPublished: February 1st 2012 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
